Cargando…
Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases
BACKGROUND: Breast cancer is the most common malignancy globally, and is considered a major cause of cancer-related death. Tremendous effort is exerted to identify an optimal anticancer drug with limited side effects. The quinoline derivative RIMHS-Qi-23 had a wide-spectrum antiproliferative activit...
Autores principales: | El-Gamal, Randa, Elfarrash, Sara, EL-Nablaway, Mohammad, Salem, Asmaa Ahmed, Zaraei, Seyed-Omar, Anbar, Hanan S., Shoma, Ashraf, El-Gamal, Mohammed I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621201/ https://www.ncbi.nlm.nih.gov/pubmed/37919708 http://dx.doi.org/10.1186/s12885-023-11547-1 |
Ejemplares similares
-
Wolfgang Rihm
por: Rihm, Wolfgang
Publicado: (1994) -
Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011–2020): Current Status and Future Prospects
por: El-Gamal, Mohammed I., et al.
Publicado: (2022) -
Gasdermin D: A potential mediator and prognostic marker of bladder cancer
por: El-Gamal, Randa, et al.
Publicado: (2022) -
Growth Diagrams for Individual Finger Strength in Children Measured with the RIHM
por: Molenaar, H. M., et al.
Publicado: (2010) -
Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori
por: Shahin, Afnan I., et al.
Publicado: (2023)